Innovative academic drug discovery a pilot study

Important results from the project

Innovative academic drug discovery a pilot study “InnoPharma” was a project coordinated by the Drug Discovery and Development platform at SciLifeLab which ended in 2023. The primary aim of the project was to propose an improved collaboration between various stakeholders in the process for evaluation and validation of academic drug discovery projects aiming for innovations and other costly projects at national research infrastructures. Included was also to analyze structural and financial prerequisites.

Expected long term effects

A collaboration model was developed where an innovation advisor is part of the project groups and where the concept of "entrepreneurial postDocs" was established. Cooperation for the use of innovation support will be continually reviewed to streamline academic pharmaceutical research. The grants to academic research and to start-ups for translational drug discovery research are insufficient. Investors testify that targeted funding for translational research has been crucial. The new collaboration model is expected to improve the conditions for funding.

Approach and implementation

DDD established a project group with a reference group appointed by the academic innovation support systems with the task of identifying bottlenecks including gaps in skills and financial support. Three academic research projects were selected and received translational research funds for utilization. The outcome was analyzed and, in parallel, a deeper analysis was also made of the support for academic pharmaceutical research. An improved collaboration model is under implementation at DDD year 2023-2024 and is assumed to be fully implemented in year 2025.

External links

Här visas med start i september det gemensamma stödet från SciLifeLab DDD och det akademinära innovationsstödet.